Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 7, 2007 - Issue 3
Submit an article Journal homepage
229
Views
0
CrossRef citations to date
0
Altmetric
Erratum

Erratum

Pages 313-314 | Published online: 09 Jan 2014

Figures & data

Figure 1. Mean plasma concentration–time curves at steady state for paroxetine IR 20 mg and paroxetine CR 25 mg.

Results from two separate studies 419 and 564. Adapted from [76]. CR: Controlled release; IR: Immediate release.

Figure 1. Mean plasma concentration–time curves at steady state for paroxetine IR 20 mg and paroxetine CR 25 mg.Results from two separate studies 419 and 564. Adapted from [76]. CR: Controlled release; IR: Immediate release.
Figure 2. Likelihood of being compliant when compared with paroxetine controlled-release, controlling for age, gender, utilization of psychiatric specialty services, titration rates and the comorbidity measures.

IR: Immediate release. Adapted from [94].

Figure 2. Likelihood of being compliant when compared with paroxetine controlled-release, controlling for age, gender, utilization of psychiatric specialty services, titration rates and the comorbidity measures.IR: Immediate release. Adapted from [94].
Figure 1. Mean plasma concentration–time curves at steady state for paroxetine IR 20 mg and paroxetine CR 25 mg.

Results from two separate studies 419 and 564. Adapted from [69]. CR: Controlled release; IR: Immediate release.

Figure 1. Mean plasma concentration–time curves at steady state for paroxetine IR 20 mg and paroxetine CR 25 mg.Results from two separate studies 419 and 564. Adapted from [69]. CR: Controlled release; IR: Immediate release.
Figure 2. Likelihood of being compliant when compared with paroxetine controlled-release, controlling for age, gender, utilization of psychiatric specialty services, titration rates and the comorbidity measures.

IR: Immediate release. Adapted from [87].

Figure 2. Likelihood of being compliant when compared with paroxetine controlled-release, controlling for age, gender, utilization of psychiatric specialty services, titration rates and the comorbidity measures.IR: Immediate release. Adapted from [87].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.